Scott A. Byrd serves as Executive at CADENCE PHARMACEUTICALS INC, where they oversee executive responsibilities. Since joining the company, Scott A. Byrd has executed 9 insider transactions totaling $674.7K, demonstrating a bearish approach to their equity position. Their most recent transaction on Mar 19, 2014 involved transacting 2,000 shares valued at $28.0K.
Scott A. Byrd currently holds 2,000 shares of CADENCE PHARMACEUTICALS INC (CADX), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Scott A. Byrd has been a net seller of CADX stock. They have purchased $14.4K and sold $660.3K worth of shares.
Scott A. Byrd's most recent insider trade was on Mar 19, 2014, when they sold 2,000 shares at $14.00 per share.
Get notified when new Form 4 filings are submitted
| $9.16 |
| Discretionary |
| Dec 2, 2013 | CADX | $27.4K | Option Exercise | 7,812 | $3.51 | Discretionary |
| Nov 15, 2013 | CADX | $36.6K | Option Exercise | 10,416 | $3.51 | Discretionary |
| Nov 15, 2013 | CADX | $83.3K | Sale | 10,416 | $8.00 | Discretionary |
| Jun 7, 2013 | CADX | $128.0K | Option Exercise | 36,458 | $3.51 | Discretionary |
| Jun 7, 2013 | CADX | $505.4K | Sale | 67,115 | $7.53 | Discretionary |
| Jun 7, 2013 | CADX | $107.6K | Option Exercise | 30,657 | $3.51 | Discretionary |
| May 10, 2011 | CADX | $14.4K | Purchase | 2,000 | $7.22 | Discretionary |